Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by canon12345on Jan 20, 2021 6:39am
275 Views
Post# 32331632

Chinese Buyout?

Chinese Buyout?With the speculation earlier this week of the chinese buying into this stock and the huge volume we saw yesterday, could a buyout be in the works? A purchaser could only accumulate 10% of the shares before declaring their position but that would not stop multiple purchasers from accumulating positions. The 3.0 is in China and if they realize the potential for this product and know of pending sales would it not make sense to take this company out now at these low levels. The 3.0 is at the stage where several hospitals globally have had a chance to test the product and the next step would be significant purchase orders? This is pure speculation on my part but the share volume suggests something very big is up! 
<< Previous
Bullboard Posts
Next >>